收稿日期: 2025-04-12
网络出版日期: 2025-07-29
基金资助
国家自然科学基金项目(81804140);湖南省卫生科研课题(20232627);湖南省2022年度“神农人才”工程学科带头人——青年神农学者项目(湘中医药[2022]4号);2022年度湖湘青年科技创新人才项目
The effect of LCN2⁃mediated EGFR phosphorylation on inflammatory injury in human fallopian tube epithelial cells
Received date: 2025-04-12
Online published: 2025-07-29
目的 探讨脂钙蛋白2(lipocalin2, LCN2)调控表皮生长因子受体(epidermal growth factor receptor, EGFR)磷酸化对人输卵管炎性上皮细胞损伤的影响。 方法 取人输卵管上皮细胞,LPS干预建立细胞模型,随机分为空白对照(Control)组、模型(Model)组、实验(Model + si-LCN2或Model + oe-LCN2)组和阴性对照(Model + si-NC或Model + oe-NC)组。探究细胞活性、细胞凋亡、细胞炎症水平、EGFRmRNA、LCN2、EGFR、p-EGFR、p-EGFR/EGFR蛋白表达水平变化。 结果 与Model组相比,Model+si-LCN2组细胞活性提升、细胞凋亡率减低,炎症因子表达下降(P < 0.05);免疫共沉淀证实LCN2与EGFR存在靶向关系。与Model组相比,Model + oe-LCN2组p-EGFR、p-EGFR/EGFR水平升高(P < 0.05),EGFR改变不大(P > 0.05)。 结论 抑制LCN2所介导的EGFR磷酸化,可提高细胞活性、减轻细胞凋亡及细胞炎症,从而改善LPS诱导的人输卵管上皮细胞炎性损伤。
关键词: 脂钙蛋白2; 人输卵管上皮细胞炎性损伤; 表皮生长因子受体; 表皮生长因子受体磷酸化
夏亚琼 , 朱悦 , 蒋呈呈 , 谭鸿平 , 张雁 , 刘玲 . LCN2介导EGFR磷酸化对人输卵管上皮细胞炎性损伤的影响[J]. 实用医学杂志, 2025 , 41(14) : 2174 -2182 . DOI: 10.3969/j.issn.1006-5725.2025.14.008
Objective To investigate the regulatory effect of lipocalin 2 (LCN2) on epidermal growth factor receptor (EGFR) phosphorylation and its impact on inflammatory damage in human fallopian tube epithelial cells. Methods Human fallopian tube epithelial cells were isolated and a lipopolysaccharide (LPS) intervention was applied to establish an in vitro cell model. The cells were randomly assigned into the following groups: a blank control group (Control), a model group (Model), experimental groups (Model + si-LCN2 or Model + oe-LCN2), and negative control groups (Model + si-NC or Model + oe-NC). Changes in cell viability, apoptosis rates, inflammatory levels, as well as the expression of EGFR mRNA, LCN2, EGFR, p-EGFR, and the ratio of p-EGFR/EGFR proteins were evaluated. Results Compared to the Model group, the Model + si-LCN2 group exhibited enhanced cell viability, a reduced apoptosis rate, and decreased expression of inflammatory factors (P < 0.05). Immunoprecipitation analysis confirmed a direct interaction between LCN2 and EGFR. In comparison with the Model group, the Model + oe-LCN2 group demonstrated elevated levels of p-EGFR and the p-EGFR/EGFR ratio (P < 0.05), while no significant change was observed in total EGFR expression (P > 0.05). Conclusion Inhibition of LCN2-mediated EGFR phosphorylation enhances cell viability, reduces apoptosis, and mitigates inflammatory responses, thereby ameliorating LPS-induced inflammatory injury in human fallopian tube epithelial cells.
| [1] | 李再仪, 马琳, 黎伟豪,等. 解脲支原体、沙眼衣原体感染与输卵管性不孕相关性研究 [J]. 中国实用妇科与产科杂志, 2019, 35(11): 1265-1268. |
| [2] | ZHANG C, LIAO W, LI W, et al. Human umbilical cord mesenchymal stem cells derived extracellular vesicles alleviate salpingitis by promoting M1-to-M2 transformation [J]. Front Physiol, 2023, 14: 1131701. doi:10.3389/fphys.2023.1131701 |
| [3] | GONZALEZ-MARTIN R, DE CASTRO P, FERNANDEZ C, et al. Proteomic Profiling Identifies Candidate Diagnostic Biomarkers of Hydrosalpinx in Endometrial Fluid: A Pilot Study[J]. Int J Mol Sci, 2024, 25(2): 968. doi:10.3390/ijms25020968 |
| [4] | ZHANG Z X, PENG J, DING W W. Lipocalin-2 and intestinal diseases [J]. World J Gastroenterol, 2024, 30(46): 4864-4879. doi:10.3748/wjg.v30.i46.4864 |
| [5] | SONG L, WU Y, YIN L, et al. Hydroxysafflower yellow A alleviates the inflammatory response in astrocytes following cerebral ischemia by inhibiting the LCN2/STAT3 feedback loop [J]. Metab Brain Dis, 2025, 40(4): 161. doi:10.1007/s11011-025-01581-2 |
| [6] | HUANG B, JIA Z, FU C, et al. Oncogenic and tumor-suppressive roles of Lipocalin 2 (LCN2) in tumor progression [J]. Oncol Res, 2025, 33(3): 567-575. doi:10.32604/or.2024.051672 |
| [7] | XU Y, QIAN X, CAI G, et al. WTX-L/β-arrestin2/LCN2 axis controls vulnerability to ferroptosis in gastric cancer [J]. iScience, 2025, 28(3): 111964. doi:10.1016/j.isci.2025.111964 |
| [8] | üNüVAR S, MELEKO?LU R, YüCE H, et al. Diagnostic utility of lipocalin 2 and metalloproteinase 9 levels in early-stage endometrial cancer [J]. Cancer Biomark, 2024, 41(3): 187585 92241290951. doi:10.1177/18758592241290951 |
| [9] | SABBAH D A, HAJJO R, SWEIDAN K. Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors [J]. Curr Top Med Chem, 2020, 20(10): 815-834. doi:10.2174/1568026620666200303123102 |
| [10] | GEKLE M, DUBOURG V, SCHWERDT G, et al. The role of EGFR in vascular AT1R signaling: From cellular mechanisms to systemic relevance [J]. Biochem Pharmacol, 2023, 217: 115837. doi:10.1016/j.bcp.2023.115837 |
| [11] | HUANG Y, HE Z, ZHOU H, et al. The Treatment of Tubal Inflammatory Infertility using Yinjia Tablets through EGFR/MEK/ERK Signaling Pathway based on Network Pharmacology [J]. Curr Pharm Biotechnol, 2024, 25(4): 499-509. doi:10.2174/0113892010234591230919074245 |
| [12] | 刘玲, 谭雅莉, 邵良, 等. 基于炎症相关信号通路探讨活血化瘀通络汤治疗输卵管炎性不孕作用机制 [J]. 时珍国医国药, 2022, 33(9): 2089-2093. |
| [13] | XU S, JIN S, YANG L, et al. Evidence-based complementary and alternative medicine conventional surgery combined with traditional Chinese medicinal retention enema for tubal obstructive infertility: A systematic review and meta-analysis [J]. PLoS One, 2023, 18(5): e0285859. doi:10.1371/journal.pone.0285859 |
| [14] | 王媛媛,刘文娟,黄莉,等. 输卵管因素不孕患者在体外受精-胚胎移植前行腹腔镜手术的获益程度 [J]. 实用医学杂志, 2023, 39 (4): 442-446. doi:10.3969/j.issn.1006-5725.2023.04.009 |
| [15] | HE Q, ZHOU Y, ZHOU W, et al. Nomogram incorporating ultrasonic markers of endometrial receptivity to determine the embryo-endometrial synchrony after in vitro fertilization [J]. Front Endocrinol (Lausanne), 2022, 13: 973306. |
| [16] | JABERI S A, COHEN A, D'SOUZA C, et al. Lipocalin-2: Structure, function, distribution and role in metabolic disorders [J]. Biomed Pharmacother, 2021, 142: 112002. doi:10.1016/j.biopha.2021.112002 |
| [17] | GUARDADO S, OJEDA-JUáREZ D, KAUL M, et al. Comprehensive review of lipocalin 2-mediated effects in lung inflammation [J]. Am J Physiol Lung Cell Mol Physiol, 2021, 321(4): L726-L733. doi:10.1152/ajplung.00080.2021 |
| [18] | 王倩倩,吴乔,杨珺丽,等. Lcn2加重巨噬细胞炎症反应并激活内质网应激和促进凋亡 [J/OL]. 中国免疫学杂志, 1-6[2025-06-03]. . |
| [19] | KRIZANAC M, MASS SANCHEZ P B, WEISKIRCHEN R, et al. Overview of the expression patterns and roles of Lipocalin 2 in the reproductive system [J]. Front Endocrinol (Lausanne), 2024, 15: 1365602. doi:10.3389/fendo.2024.1365602 |
| [20] | BEGHINI J, GIRALDO P C, ELEUTéRIO J Jr, et al. Vaginal Inflammation: Association between Leukocyte Concentration and Levels of Immune Mediators [J]. Am J Reprod Immunol, 2016, 75(2): 126-133. doi:10.1111/aji.12475 |
| [21] | AN X, QIN J, HU X, et al. Overexpression of lipocalin 2 in PBX1-deficient decidual NK cells promotes inflammation at the maternal-fetal interface [J]. Am J Reprod Immunol, 2023, 89(3): e13676. doi:10.1111/aji.13676 |
| [22] | TSAI H T, SU P H, LEE T H, et al. Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease [J]. Clin Chim Acta, 2011, 412(13-14): 1252-1256. doi:10.1016/j.cca.2011.03.021 |
| [23] | 李玉婷,颜琦璐,宋启斌. 非小细胞肺癌表皮生长因子受体靶向治疗的研究进展 [J]. 实用医学杂志, 2024, 40 (15): 2166-2171. |
| [24] | 徐皓男,张放,黄钰莹,等. 百蕊草通过调节肠道菌群和调控EGFR/PI3K/Akt信号通路改善小鼠抗生素相关性腹泻[J]. 南方医科大学学报,2025,45(2):285-295. |
| [25] | TOUFIG H, BENAMEUR T, TWFIEG M E, et al. Evaluation of hysterosalpingographic findings among patients presenting with infertility [J]. Saudi J Biol Sci, 2020, 27(11): 2876-2882. doi:10.1016/j.sjbs.2020.08.041 |
| [26] | LIU N, GUO J K, PANG M, et al. Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis [J]. J Am Soc Nephrol, 2012, 23(5): 854-867. doi:10.1681/asn.2011050493 |
| [27] | SHAO L, WANG N, YAN Y, et al. Quercetin of huoxuehuayu tongluo decoction and azithromycin combination therapy effectively improves rat tubal factor infertility by inhibiting inflammation [J]. Iran J Basic Med Sci, 2024, 27(6): 685-694. |
| [28] | YAMMINE L, ZABLOCKI A, BARON W, et al. Lipocalin-2 Regulates Epidermal Growth Factor Receptor Intracellular Trafficking [J]. Cell Rep, 2019, 29(7): 2067-2077. doi:10.1016/j.celrep.2019.10.015 |
/
| 〈 |
|
〉 |